Search: onr:"swepub:oai:gup.ub.gu.se/310527" >
Sex disparities in ...
Sex disparities in long-term mortality after paclitaxel exposure in patients with peripheral artery disease: A nationwide claims-based cohort study
- Article/chapterUndefined language2021
Publisher, publication year, extent ...
Numbers
-
LIBRIS-ID:oai:gup.ub.gu.se/310527
-
https://gup.ub.gu.se/publication/310527URI
-
https://doi.org/10.3390/jcm10132978DOI
Supplementary language notes
-
Language:Undefined language
Part of subdatabase
Classification
-
Subject category:ref swepub-contenttype
-
Subject category:art swepub-publicationtype
Notes
-
Background: Randomized controlled trials have reported excess mortality in patients treated with paclitaxel-coated devices versus uncoated devices, while observational studies have reported the opposite. This study aims to determine the underlying factors and cohort differences that may explain these opposite results, with specific focus on sex differences in treatment and outcomes. Methods: Multicenter health insurance claims data from a large insurance fund, BARMER, were studied. A homogeneous sample of patients with an index of endovascular revascularization for symptomatic peripheral arterial occlusive disease between 2013 and 2017 was included. Adjusted logistic regression and Cox regression models were used to determine the factors predicting allocation to paclitaxel-coated devices and sex-specific 5-year all-cause mortality, respectively. Results: In total, 13,204 patients (54% females, mean age 74 ± 11 years) were followed for a median of 3.5 years. Females were older (77 vs. 71 years), and had less frequent coronary artery disease (23% vs. 33%), dyslipidemia (44% vs. 50%), and diabetes (29% vs. 41%), as well as being less likely to have a history of smoking (10% vs. 15%) compared with males. Mortality differences were mostly attributable to the female subgroup who were revascularized above the knee (hazard ratio, HR 0.78, 95% CI: 0.64–0.95), while no statistically significant differences were observed in males. Conclusions: This study found that females treated above the knee benefited from paclitaxel-coated devices, while no differences were found in males. Ongoing and future registries and trials should take sex disparities into account.
Subject headings and genre
Added entries (persons, corporate bodies, meetings, titles ...)
-
Sedrakyan, A.
(author)
-
Katsanos, K.
(author)
-
Nordanstig, JoakimGothenburg University,Göteborgs universitet,Institutionen för medicin, avdelningen för molekylär och klinisk medicin,Institute of Medicine, Department of Molecular and Clinical Medicine(Swepub:gu)xnjoak
(author)
-
Kuchenbecker, J.
(author)
-
Kreutzburg, T.
(author)
-
Secemsky, E. A.
(author)
-
Debus, E. S.
(author)
-
Marschall, U.
(author)
-
Peters, F.
(author)
-
Göteborgs universitetInstitutionen för medicin, avdelningen för molekylär och klinisk medicin
(creator_code:org_t)
Related titles
-
In:Journal of Clinical Medicine: MDPI AG10:132077-0383
Internet link
Find in a library
To the university's database
- By the author/editor
-
Behrendt, C. A.
-
Sedrakyan, A.
-
Katsanos, K.
-
Nordanstig, Joak ...
-
Kuchenbecker, J.
-
Kreutzburg, T.
-
show more...
-
Secemsky, E. A.
-
Debus, E. S.
-
Marschall, U.
-
Peters, F.
-
show less...
- About the subject
-
- MEDICAL AND HEALTH SCIENCES
-
MEDICAL AND HEAL ...
-
and Clinical Medicin ...
-
and Cardiac and Card ...
- Articles in the publication
-
Journal of Clini ...
- By the university
-
University of Gothenburg